NM_006005.3:c.-5-131C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006005.3(WFS1):​c.-5-131C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.806 in 866,530 control chromosomes in the GnomAD database, including 282,898 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.82 ( 50814 hom., cov: 34)
Exomes 𝑓: 0.80 ( 232084 hom. )

Consequence

WFS1
NM_006005.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.899

Publications

12 publications found
Variant links:
Genes affected
WFS1 (HGNC:12762): (wolframin ER transmembrane glycoprotein) This gene encodes a transmembrane protein, which is located primarily in the endoplasmic reticulum and ubiquitously expressed with highest levels in brain, pancreas, heart, and insulinoma beta-cell lines. Mutations in this gene are associated with Wolfram syndrome, also called DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness), an autosomal recessive disorder. The disease affects the brain and central nervous system. Mutations in this gene can also cause autosomal dominant deafness 6 (DFNA6), also known as DFNA14 or DFNA38. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]
WFS1 Gene-Disease associations (from GenCC):
  • Wolfram-like syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics, ClinGen, Orphanet
  • Wolfram syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • autosomal dominant nonsyndromic hearing loss 6
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cataract 41
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Wolfram syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • type 2 diabetes mellitus
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 4-6277320-C-T is Benign according to our data. Variant chr4-6277320-C-T is described in ClinVar as Benign. ClinVar VariationId is 1257985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.922 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WFS1NM_006005.3 linkc.-5-131C>T intron_variant Intron 1 of 7 ENST00000226760.5 NP_005996.2
WFS1NM_001145853.1 linkc.-1-135C>T intron_variant Intron 1 of 7 NP_001139325.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WFS1ENST00000226760.5 linkc.-5-131C>T intron_variant Intron 1 of 7 1 NM_006005.3 ENSP00000226760.1

Frequencies

GnomAD3 genomes
AF:
0.815
AC:
124027
AN:
152098
Hom.:
50767
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.833
Gnomad AMI
AF:
0.834
Gnomad AMR
AF:
0.859
Gnomad ASJ
AF:
0.845
Gnomad EAS
AF:
0.944
Gnomad SAS
AF:
0.822
Gnomad FIN
AF:
0.752
Gnomad MID
AF:
0.845
Gnomad NFE
AF:
0.792
Gnomad OTH
AF:
0.838
GnomAD4 exome
AF:
0.804
AC:
574508
AN:
714314
Hom.:
232084
AF XY:
0.804
AC XY:
299047
AN XY:
371774
show subpopulations
African (AFR)
AF:
0.831
AC:
15565
AN:
18738
American (AMR)
AF:
0.878
AC:
29603
AN:
33700
Ashkenazi Jewish (ASJ)
AF:
0.856
AC:
16005
AN:
18700
East Asian (EAS)
AF:
0.968
AC:
31613
AN:
32668
South Asian (SAS)
AF:
0.817
AC:
47918
AN:
58682
European-Finnish (FIN)
AF:
0.758
AC:
34401
AN:
45358
Middle Eastern (MID)
AF:
0.846
AC:
2448
AN:
2892
European-Non Finnish (NFE)
AF:
0.786
AC:
368249
AN:
468226
Other (OTH)
AF:
0.812
AC:
28706
AN:
35350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
6635
13270
19905
26540
33175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5072
10144
15216
20288
25360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.816
AC:
124133
AN:
152216
Hom.:
50814
Cov.:
34
AF XY:
0.815
AC XY:
60608
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.833
AC:
34606
AN:
41530
American (AMR)
AF:
0.859
AC:
13156
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.845
AC:
2934
AN:
3472
East Asian (EAS)
AF:
0.944
AC:
4876
AN:
5164
South Asian (SAS)
AF:
0.823
AC:
3968
AN:
4824
European-Finnish (FIN)
AF:
0.752
AC:
7974
AN:
10600
Middle Eastern (MID)
AF:
0.847
AC:
249
AN:
294
European-Non Finnish (NFE)
AF:
0.792
AC:
53835
AN:
67996
Other (OTH)
AF:
0.838
AC:
1774
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1192
2384
3575
4767
5959
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
884
1768
2652
3536
4420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.791
Hom.:
4855
Bravo
AF:
0.825
Asia WGS
AF:
0.879
AC:
3057
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.15
DANN
Benign
0.50
PhyloP100
-0.90
PromoterAI
-0.0033
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10937714; hg19: chr4-6279047; API